94 filings
Page 2 of 5
8-K
vykidx 83
8 Feb 22
Results of Operations and Financial Condition
1:44pm
8-K
66box jdlge
22 Nov 21
Results of Operations and Financial Condition
4:05pm
8-K
0j5n7z
23 Aug 21
Departure of Directors or Certain Officers
4:01pm
8-K
8hnp47m01a06i spig
5 Aug 21
Results of Operations and Financial Condition
4:03pm
8-K
vke47qlkx8w
16 Jul 21
Departure of Directors or Certain Officers
4:06pm
8-K
kbyg049 nq4x
6 May 21
Results of Operations and Financial Condition
4:03pm
8-K
dhmq4soa6 dwx
5 Mar 21
Departure of Directors or Certain Officers
4:00pm
8-K
cfbj1mbkbdm 2y3ix
8 Feb 21
Results of Operations and Financial Condition
4:05pm
8-K
begu4c8
5 Feb 21
Other Events
4:31pm
8-K
5bbru8lh0ba5e 533
4 Dec 20
Departure of Directors or Certain Officers
4:00pm
8-K
ecw9qzi5tr02aohq5
23 Nov 20
Results of Operations and Financial Condition
4:05pm
8-K
de5bnvl p24
4 Aug 20
Results of Operations and Financial Condition
4:16pm
8-K
1k1ucrm959ny
30 Jun 20
Departure of Directors or Certain Officers
4:00pm
8-K
hk8vnwpp
6 May 20
Results of Operations and Financial Condition
4:09pm
8-K
jsenlm 4r4647ef
2 Mar 20
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
30qtimfu
6 Feb 20
Positive results from part 1 of the Phase 1a/b clinical study ofEDP-514 in healthy subjects
4:14pm
8-K
cxmm52
21 Nov 19
Results of Operations and Financial Condition
4:05pm
8-K
bq03fmt2
6 Aug 19
Royalty revenue for the quarter was $44.4 million
4:06pm
8-K
bezk1p qm6voy
7 May 19
Data from Phase 2a RSV program anticipated mid-2019 and Phase 2a NASH program by the end of third quarter of calendar 2019
4:04pm
8-K/A
smrqd30dh
7 Mar 19
Departure of Directors or Certain Officers
4:15pm